CORRELATION OF THE USE OF CONTRACEPTIVE PILL COMBINATION TO RISK OF LEIOMYOMA EVENTS IN RSPAL SURABAYA
Abstract
The use of contraception is important to control population growth, regulate the interval between pregnancies, avoid unwanted births, control the time of birth in a husband and wife relationship and determine the number of children in the family. According to the Central Statistics Agency (BPS) of East Java Province in 2018, the number of active Family Planning (KB) participants of married women of childbearing age who use hormonal contraception in the form of pills was 19.26%, injections were 50.44%, and implants is 11. 45%. Uterine fibroids occur in 20%-25% of women of reproductive age. The prevalence of leiomyoma may increase with hormonal contraceptives containing the hormone estrogen, either pure or combined. Uterine fibroids can affect the quality of life of the sufferer.
Purpose: To analyze the relationship between the use of combined pill contraceptives and those who do not use the combined pill contraception in women with the incidence of leiomyoma.
Method: This research is an observational analytic carried out retrospectively with a case-control approach. The sampling technique in this study was non-probability sampling, namely purposive sampling. This study uses secondary data, namely medical records of gynecological patients at the RSPAL Dr. Ramelan Surabaya by meeting the inclusion criteria and exclusion criteria. The data collected will be analyzed by looking at whether leiomyoma patients use combined pill contraception.
Result: Patients diagnosed with leiomyoma who used the combined pill contraceptive were 48 (63%), while those who did not use the combined pill were 28 (37%). This study's results indicate a significant relationship between the use of combined pill contraceptives and the incidence of leiomyoma (p=0.001).
Conclusion: There is a relationship between the use of combined pill contraceptives with the incidence of leiomyoma.
Save to Mendeley
Keywords
Full Text:
PDFReferences
Liwang F, Bhargah A, Kusuma IBH, Prathiwindya GG, Indaya IG, Putra S, et al. Gambaran penggunaan kontrasepsi hormonal dan non hormonal di wilayah kerja UPT Puskesmas Tampak Siring 1. Fak Kedokt Univ Sam Ratulangi. 2018;9(3):41–6.
Timur BK dan KBNPJ. Jumlah Pasangan Usia Subur dan Peserta KB Aktif di Provinsi JawaTimur Menurut Kabupaten/Kota, 2018 [Internet]. Surabaya: Badan Pusat Statistik Provinsi Jawa Timur; 2018. Available from: https://jatim.bps.go.id/statictable/2019/10/09/1683/jumlah-pasangan-usia-subur-dan-peserta-kb-aktif-di-provinsi-jawatimur-menurut-kabupaten-kota-2018-.html.
Murti, Naomi. Analisis Faktor Pemicu Perkembangan Mioma Uteri pada Wanita Dewasa Akhir. 2019.
Lilyani DI, Sudiat M, Basuki R. Hubungan Faktor Risiko dan Kejadian Mioma Uteri di Rumah Sakit Umum Daerah Tugurejo Semarang. J Kedokt Muhammadiyah. 2012;1(1):14–9.
Pasinggi S, Wagey F, Rarung M. Prevalensi Mioma Uteri Berdasarkan Umur Di Rsup Prof. Dr. R. D. Kandou Manado. e-CliniC. 2015;3(1).
Izza N. Kejadian Mioma Uteri Pada Perempuan Di Perkotaan Indonesia. 2020;89–98.
Bieber EJ, Sanfilippo JS. Clinical Gynecology. second edi. United Kingdom: Cambridge University Press; 2015.
Amin M Al, Juniati D. Klasifikasi Kelompok Umur Manusia Berdasarkan Analisis Dimensi Fraktal Box Counting Dari Citra Wajah Dengan Deteksi Tepi Canny. J Ilm Mat [Internet]. 2017;2(6):34. Available from: https://media.neliti.com/media/publications/249455-none-23b6a822.pdf
Sumiati S, Erlindawati. Faktor-Faktor Yang Berhubungan Dengan Mioma Uteri Di Rumah Sakit Kota Bengkulu Tahun 2012. J Media Kesehat [Internet]. 2012;vol 5, No(3):101–205. Available from: http://jurnal.poltekkes-kemenkes-bengkulu.ac.id/index.php/jmk/article/view/191.
Ying J, Nie D. The relationship between the use of oral contraceptives and the risk of uterine leiomyoma in women of child bearing age of Han Chinese. Pharm Bioprocess. 2018;6(2):48–52.
DOI: https://doi.org/10.33508/jwmj.v4i3.4098
Refbacks
- There are currently no refbacks.